YH-306

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 3789

CAS [1373764-75-0]

MF C19H18N2O2
MW 306.36

  • Purity: 99%
  • Soluble in DMSO and EtOH
Recently added

YH-306

Description

YH-306 blocks the activation of FAK and FAK-related signaling pathways, leading to the suppression of CRC growth and metastasis. In vitro, YH-306 significantly inhibited CRC cell migration, invasion, proliferation and colonization, and induced CRC cell apoptosis. In vivo, YH-306 depressed CRC growth and suppressed hepatic/pulmonary metastasis.

KEYWORDS: YH-306 | Supplier | FAK inhibitor | YH306 | YH 306 | CAS [1373764-75-0] | Non Selective (Phosphorylation substrates) | FAK | Inhibitor | Enzymes | TGFβ | Lung cancer | Breast cancer | Colorectal cancer | CRC | PI3K | Rac1

Order
Size Unit Price Stock
10 mg €90.00 In Stock
50 mg €270.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...